Category: Research
... over 45 cases at JHH annually. ESCaPMs are resistant to most common antibiotics, and the best treament for them is not known. Current ... guidelines recommend using meropenem, one of the most powerful antibiotics in our armamentarium and the last line of defence against antbiotic resistant bacteria. Since overuse of particular antibiotics can lead to bacterial resistance (at a community or hospital ...
Category: Researcher Profiles
... disease that target neutrophilic inflammation such as macrolide antibiotics. Identifying the mechanisms of neutrophilic inflammation - ... first randomised controlled trials of macrolide therapy (a type of antibiotics) for patients with difficult asthma and more recently for ... project grant in an Australia-wide multicentre study of macrolide antibiotics in asthma (AMAZES) which is nearing completion. At the time ...
Category: News & Articles
A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is ... years after it commenced. A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is ... tablet. “We showed in a previous study of 45 people that macrolide antibiotics can reduce inflammation and improve quality of life for ...
Category: News & Articles
New research is underway to test the effectiveness of combining antibiotics with commonly used treatments to help people with asthma ... New research is underway to test the effectiveness of combining antibiotics with commonly used treatments to help people with asthma ... Day New research is underway to test the effectiveness of combining antibiotics with current treatments to help people with asthma better ...
Category: Researcher Profiles
... to develop a new treatment for non-eosinophilic asthma with macrolide antibiotics. Eosinophils are a form of white blood cells in the immune ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. Project ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... the development of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. Project ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... the development of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. Project ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... the development of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema. ... COPD. Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which ... of COPD, as well as during standard treatments with steroids and antibiotics in mice. 2. Assess for the same changes in gut microviomes ...
Category: News & Articles
... As one of the greatest health challenges facing humanity, the antibiotics currently used to treat infections are becoming increasingly ... OUTBREAK (One-health Understanding Through Bacterial REsistance to Antibiotics Knowledge) will be led by the University of Technology ...
